
Angela A. Armstrong
Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2641, 2741, 2654, 2626 |
| Total Applications | 1003 |
| Issued Applications | 675 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5953936
[patent_doc_number] => 20110034419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease'
[patent_app_type] => utility
[patent_app_number] => 12/824904
[patent_app_country] => US
[patent_app_date] => 2010-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27134
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12824904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/824904 | Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease | Jun 27, 2010 | Abandoned |
Array
(
[id] => 8186496
[patent_doc_number] => 20120115794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/378574
[patent_app_country] => US
[patent_app_date] => 2010-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11431
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115794.pdf
[firstpage_image] =>[orig_patent_app_number] => 13378574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378574 | USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES | Jun 10, 2010 | Abandoned |
Array
(
[id] => 6608271
[patent_doc_number] => 20100323380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION'
[patent_app_type] => utility
[patent_app_number] => 12/797144
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6925
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323380.pdf
[firstpage_image] =>[orig_patent_app_number] => 12797144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797144 | METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION | Jun 8, 2010 | Abandoned |
Array
(
[id] => 8197001
[patent_doc_number] => 20120121579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 13/375504
[patent_app_country] => US
[patent_app_date] => 2010-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18597
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121579.pdf
[firstpage_image] =>[orig_patent_app_number] => 13375504
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/375504 | TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE | Jun 1, 2010 | Abandoned |
Array
(
[id] => 8208992
[patent_doc_number] => 20120128660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'DIAGNOSIS OF RESTENOSIS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION'
[patent_app_type] => utility
[patent_app_number] => 13/375924
[patent_app_country] => US
[patent_app_date] => 2010-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10433
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128660.pdf
[firstpage_image] =>[orig_patent_app_number] => 13375924
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/375924 | Diagnosis of restenosis in patients undergoing percutaneous coronary intervention | Jun 1, 2010 | Issued |
Array
(
[id] => 8920469
[patent_doc_number] => 08486400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling'
[patent_app_type] => utility
[patent_app_number] => 12/791785
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 38
[patent_no_of_words] => 50746
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12791785
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791785 | Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling | May 31, 2010 | Issued |
Array
(
[id] => 8549480
[patent_doc_number] => 08324362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors'
[patent_app_type] => utility
[patent_app_number] => 12/788240
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 41355
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/788240 | Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors | May 25, 2010 | Issued |
Array
(
[id] => 6597306
[patent_doc_number] => 20100292172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 12/785396
[patent_app_country] => US
[patent_app_date] => 2010-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 46464
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12785396
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/785396 | Peptide-peptidase inhibitor conjugates and methods of using same | May 20, 2010 | Issued |
Array
(
[id] => 7586864
[patent_doc_number] => 20110281374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'BIOMARKER'
[patent_app_type] => utility
[patent_app_number] => 12/778230
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4044
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281374.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778230 | BIOMARKER | May 11, 2010 | Abandoned |
Array
(
[id] => 8228400
[patent_doc_number] => 20120142605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHODS OF TREATING PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 13/319004
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10995
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319004
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319004 | METHODS OF TREATING PSORIASIS | May 4, 2010 | Abandoned |
Array
(
[id] => 6186203
[patent_doc_number] => 20110124556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'Insulin and IGF-1 Receptor Agonists and Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/763964
[patent_app_country] => US
[patent_app_date] => 2010-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 122
[patent_figures_cnt] => 122
[patent_no_of_words] => 48855
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12763964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/763964 | Insulin and IGF-1 Receptor Agonists and Antagonists | Apr 19, 2010 | Abandoned |
Array
(
[id] => 8624874
[patent_doc_number] => 08357368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Methods of treating pancreatic or liver cancer using hedgehog antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/756939
[patent_app_country] => US
[patent_app_date] => 2010-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 55
[patent_no_of_words] => 60226
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/756939 | Methods of treating pancreatic or liver cancer using hedgehog antagonists | Apr 7, 2010 | Issued |
Array
(
[id] => 7754817
[patent_doc_number] => 20120027850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Compositions and Methods for Treatment of Aortic Fibrosis'
[patent_app_type] => utility
[patent_app_number] => 13/262064
[patent_app_country] => US
[patent_app_date] => 2010-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3555
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027850.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262064 | Methods for the treatment of aortic fibrosis with VIP fragments | Apr 5, 2010 | Issued |
Array
(
[id] => 5938241
[patent_doc_number] => 20110213209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'MONITORING MYOCARDIAL INFARCTION AND ITS TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/748476
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10541
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20110213209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748476
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748476 | Monitoring myocardial infarction and its treatment | Mar 28, 2010 | Issued |
Array
(
[id] => 6186291
[patent_doc_number] => 20110124580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/728948
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27752
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728948 | REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO | Mar 21, 2010 | Abandoned |
Array
(
[id] => 8041427
[patent_doc_number] => 20120070451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING CARDIAC CONTRACTILITY'
[patent_app_type] => utility
[patent_app_number] => 13/257590
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13056
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20120070451.pdf
[firstpage_image] =>[orig_patent_app_number] => 13257590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257590 | METHODS AND COMPOSITIONS FOR MODULATING CARDIAC CONTRACTILITY | Mar 18, 2010 | Abandoned |
Array
(
[id] => 9245325
[patent_doc_number] => 08609605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100'
[patent_app_type] => utility
[patent_app_number] => 13/257045
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13116
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257045 | Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100 | Mar 16, 2010 | Issued |
Array
(
[id] => 6635460
[patent_doc_number] => 20100226884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)'
[patent_app_type] => utility
[patent_app_number] => 12/722645
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 30054
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226884.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722645 | Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) | Mar 11, 2010 | Abandoned |
Array
(
[id] => 6635348
[patent_doc_number] => 20100226878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/716986
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14872
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226878.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716986 | Methods of inhibiting photoreceptor apoptosis | Mar 2, 2010 | Issued |
Array
(
[id] => 9020206
[patent_doc_number] => 08530191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Method for preventing formation of trisulfide derivatives of polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/714900
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4996
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714900 | Method for preventing formation of trisulfide derivatives of polypeptides | Feb 28, 2010 | Issued |